Short Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Drops By 32.2%

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 141,300 shares, a decline of 32.2% from the February 28th total of 208,400 shares. Approximately 0.8% of the company's shares are sold short. Based on an average daily volume of 87,900 shares, the short-interest ratio is presently 1.6 days.

BioStem Technologies Stock Performance

Shares of OTCMKTS BSEM traded up $0.45 during mid-day trading on Thursday, reaching $8.20. The company had a trading volume of 82,941 shares, compared to its average volume of 60,249. The company has a market capitalization of $136.97 million, a price-to-earnings ratio of 12.06 and a beta of -0.39. The stock has a fifty day moving average of $12.95 and a two-hundred day moving average of $13.80. BioStem Technologies has a 12-month low of $6.77 and a 12-month high of $28.26.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.